Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1.
Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1. Neuro Oncol. 2022 08 01; 24(8):1377-1386.